Mandatory Research Biopsy Requirements Delay Initiation of Clinical Trials
Background: There has been an increasing requirement for fresh tumor tissue to enroll in clinical trials in order to look for specific biomarkers. This has been shown to increase screening duration and increase screen failure rates. It was important to corroborate these results in other centers.Meth...
Main Authors: | Jonathan H. Cheng, Justin W. Tiulim, Sheng Zhou, Anthony El-Khoueiry, Jorge Nieva |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00968/full |
Similar Items
-
Prostate Biopsy in the Case of PIRADS 5—Is Systematic Biopsy Mandatory?
by: Wojciech Malewski, et al.
Published: (2023-08-01) -
Model of Union Two Mandatory Security Policies
by: Y. S. Rakitskiy, et al.
Published: (2011-03-01) -
Blood-Derived Liquid Biopsies Using Foundation One<sup>®</sup> Liquid CDx for Children and Adolescents with High-Risk Malignancies: A Monocentric Experience
by: Fanny Cahn, et al.
Published: (2022-06-01) -
Mandatory rules in recent Serbian jurisprudence and contractual practice
by: Hiber Dragor
Published: (2022-01-01) -
Mandatory acquisition of shares: Procedure
by: Arsić Zoran V.
Published: (2016-01-01)